Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/30/26 | Samsung Bioepis | SB27 for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/26/26 | Nippon (4516) | deramiocel for Duchenne Muscular Dystrophy (DMD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/23/26 | Sanofi (SNY) | Wayrilz for Immune Thrombocytopenic Purpura (ITP) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/23/26 | Corxel Pharmaceuticals | VCT 220 for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/22/26 | Achieve Life Sciences (ACHV) | Tabex for Smoking Cessation | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/17/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |